Navigating the Highs and Lows: Bipolar Disorder I Explained

Most people have days when they feel unusually energized, driven, and unstoppable – and other days when even getting out of bed feels impossible. For most of us, these shifts are temporary. But for people living with Bipolar Disorder I, these mood states are far more extreme, lasting for days or weeks, and they can profoundly disrupt daily life. Understanding what Bipolar I actually involves – beyond the common misconceptions – is essential for both those living with it and those who support them.

What is Bipolar Disorder I? 🔗

Bipolar disorder is a chronic mood disorder that causes intense shifts in mood, energy levels, and behavior. It is not simply feeling happy one day and sad the next – it involves distinct mood episodes that are clinically significant, identifiable, and often debilitating. According to the National Library of Medicine, bipolar disorder is characterized by chronically recurring episodes of mania or hypomania alternating with depression, and it is among the top 10 leading causes of disability worldwide.

Within the bipolar spectrum, Bipolar I is considered the most severe subtype. The key feature of Bipolar I disorder is at least one full manic episode lasting a minimum of one week – or of any duration if hospitalization is required. A depressive episode is not required for the diagnosis, though most people with Bipolar I will experience periods of depression as well. This distinguishes it clearly from Bipolar II, which involves hypomanic (milder) episodes and requires at least one major depressive episode.

The manic episode: more than just a good mood 🔗

Mania is often misunderstood as simply feeling very happy or productive. In reality, a manic episode is a distinct, abnormal state that is noticeable to others and represents a marked departure from a person’s usual behavior. According to DSM-5 criteria, a manic episode requires an abnormally and persistently elevated, expansive, or irritable mood – along with abnormally increased energy or activity – lasting at least one week.

Core symptoms of mania 🔗

During a manic episode, at least three of the following symptoms must be present (or four if the mood is only irritable), representing a significant change from usual behavior:

• Inflated self-esteem or grandiosity – feeling invincible, unusually talented, or specially chosen
• Decreased need for sleep – feeling rested after only two or three hours
• Pressured speech – talking more than usual, faster, or feeling unable to stop
• Racing thoughts or flight of ideas – thoughts moving so quickly they are hard to track
• Distractibility – attention pulled easily to unimportant stimuli
• Goal-directed hyperactivity – excessive involvement in work, social activities, or sexual behavior
• Risky or impulsive behavior – unrestrained spending, reckless driving, or ill-advised financial or sexual decisions

People in manic states may indulge in activities that cause physical, social, or financial harm, often without recognizing the risk at the time. In severe cases, psychotic symptoms such as delusions or hallucinations can also emerge during mania, which can make the episode harder to distinguish from other psychiatric conditions.

It is also worth noting that the DSM-5 introduced a “mixed features” specifier to capture episodes where symptoms of both mania and depression occur simultaneously – a pattern that was inadequately described in earlier diagnostic frameworks. During a mixed episode, a person might feel intensely energized yet deeply hopeless, sometimes cycling between extremes within a matter of hours.

The depressive side of Bipolar I 🔗

While mania defines the diagnosis of Bipolar I, depression is often where people spend more of their time – and where the condition does the most damage to daily functioning. Research shows that bipolar disorder is the leading cause of years lost to disability worldwide, with depression considered more disabling than mania. Even minor or subsyndromal depressive symptoms have a strong impact on a person’s ability to work and maintain relationships.

A major depressive episode in the context of Bipolar I involves at least five of the following symptoms persisting for two or more weeks, with at least one being depressed mood or loss of interest (anhedonia):

• Depressed mood for most of the day
• Loss of interest or pleasure in activities once enjoyed
• Significant changes in appetite or weight
• Sleep disturbances – insomnia or sleeping too much
• Physical slowing or agitation
• Fatigue or loss of energy
• Feelings of worthlessness or excessive guilt
• Difficulty concentrating or making decisions
• Recurrent thoughts of death or suicidal ideation

One important clinical challenge is that distinguishing between unipolar depression and bipolar depression is particularly difficult because both types share the same general depressive symptom criteria. This is why clinicians must always ask about any history of manic or hypomanic episodes – especially in patients who present with depression for the first time before age 25, or who have had five or more depressive episodes over their lifetime.

Who is affected and why does it happen? 🔗

Approximately 2.8% of U.S. adults experience bipolar disorder annually, with onset typically occurring in late adolescence or early adulthood. The cause of bipolar disorder is currently unknown but appears to result from an interaction of genetic, epigenetic, neurochemical, and environmental factors. Heritability is well established – those with a first-degree relative diagnosed with bipolar disorder or schizophrenia face a considerably elevated risk.

Environmental stressors, significant life events, disrupted sleep patterns, and substance use can all act as triggers for mood episodes in individuals who are genetically predisposed. This interplay between biology and environment is why no two people experience Bipolar I in exactly the same way.

Diagnosing Bipolar I: why it takes time 🔗

Bipolar I is frequently misdiagnosed – most often as major depressive disorder – because people tend to seek help during depressive episodes rather than manic ones. During mania, many individuals feel good and don’t recognize a problem. Bipolar disorder is often difficult to recognize because symptoms overlap with other psychiatric disorders, and patients may lack insight into their own condition, particularly during hypomania or mania.

Diagnosis is based on a comprehensive psychiatric evaluation using the DSM-5 criteria established by the American Psychiatric Association. There are no blood tests or brain scans that confirm the diagnosis – it relies on careful clinical assessment, patient history, and in many cases, information from family members or close contacts who can describe behavioral changes over time.

Bipolar I vs. Bipolar II: key distinction 🔗

Bipolar I requires at least one manic episode lasting one week or leading to hospitalization, while Bipolar II requires at least one depressive episode and one hypomanic episode – with no full manic episodes. This is a critical distinction. Hypomania is less severe than mania: it doesn’t cause the same level of functional impairment and doesn’t involve psychosis. Contrary to what some assume, Bipolar II is not a milder condition overall – its higher burden of chronic depression can make it equally debilitating in different ways.

Treatment: a long-term, comprehensive strategy 🔗

Bipolar I is a lifelong condition, but it is highly manageable with the right treatment plan. An effective treatment plan usually includes a combination of psychotherapy, medications, self-management strategies, and in some cases, other interventions such as electroconvulsive therapy (ECT). There is no single solution – treatment is typically tailored to the individual and evolves over time.

Medication 🔗

Pharmacotherapy with mood stabilizers – such as lithium, anticonvulsants, and antipsychotics – is a first-line treatment that should generally be continued indefinitely due to the high risk of relapse. Lithium in particular has long been considered a cornerstone medication for Bipolar I. Importantly, antidepressant monotherapy is contraindicated during manic episodes and in Bipolar I overall, as antidepressants used alone can trigger or worsen manic episodes.

Psychotherapy 🔗

Medication alone is rarely sufficient. Psychotherapy is a crucial component of evidence-based outpatient treatment for bipolar disorder, helping individuals manage mood episodes, improve medication adherence, and maintain psychosocial functioning. Evidence-backed approaches include Cognitive Behavioral Therapy (CBT), which helps identify and reframe negative thought patterns; Interpersonal and Social Rhythm Therapy (IPSRT), which focuses on stabilizing daily routines and sleep schedules to reduce mood fluctuations; and Family-Focused Therapy (FFT), which involves loved ones in the treatment process to improve communication and recognize early warning signs of relapse.

Research shows that patients who receive intensive psychotherapy have fewer relapses and longer periods of relative wellness compared to those who receive only brief therapy. Psychoeducation – educating both the individual and their family about the nature of the disorder – is also a foundational part of any treatment plan.

Hospitalization 🔗

In severe cases, inpatient care becomes necessary. Hospitalization is usually indicated when a patient poses a serious threat of harm to themselves or others, has significantly impaired judgment, lacks adequate social support, or has not responded to outpatient treatment. During an inpatient stay, patients receive medication management, psychotherapy, and continuous monitoring by a multidisciplinary team aimed at stabilizing mood and preventing crisis. The goal is to stabilize the acute episode and transition the person back to community-based care as safely as possible.

Lifestyle and ongoing management 🔗

All patients with bipolar disorder need regular outpatient monitoring for both medications and psychotherapy, with consistent follow-up that allows clinicians to catch early signs of a new episode. Beyond formal treatment, lifestyle factors play a meaningful supportive role. Maintaining regular sleep patterns, avoiding alcohol and recreational drugs, managing stress, and building a strong social support network all contribute to long-term stability. Patients who have social support in recognizing early warning signs of recurrence appear to have less risk of relapse and hospitalization, and better overall functioning.

Living with Bipolar I: the importance of understanding 🔗

Bipolar I disorder is not a character flaw or a lack of willpower – it is a serious, neurobiological condition that responds well to structured, evidence-based treatment. Early and accurate diagnosis, combined with consistent medication, therapy, and support, gives people living with Bipolar I a strong foundation for a stable and meaningful life. The road is not always linear, but with the right resources and understanding, recovery and long-term management are very much achievable.

What do you think? How does understanding the clinical distinction between a manic episode and everyday high energy change the way you think about Bipolar I? And considering that depression is often the more disabling phase of the condition, how might that reshape the way we talk about and support people with this diagnosis?

References

1. https://my.clevelandclinic.org/health/diseases/9294-bipolar-disorder
2. https://www.ncbi.nlm.nih.gov/books/NBK558998/
3. https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le7549b.pdf
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC4116292/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC10198128/
6. https://www.voguerecoverycenter.com/rehab-blog/what-is-inpatient-treatment-for-bipolar-disorder/
7. https://www.healthcentral.com/condition/bipolar-disorder/bipolar-dsm-5-criteria
8. https://www.medcentral.com/behavioral-mental/bipolar-disorder/assessment-diagnosis-adherence-bipolar-disorder
9. https://www.aafp.org/pubs/afp/issues/2021/0215/p227.html
10. https://www.psychiatryonline.org/doi/10.1176/foc.1.1.64
11. https://emedicine.medscape.com/article/286342-treatment